Interactions Between the Flk-1 Receptor, Vascular Endothelial Growth Factor, and Cell Surface Proteoglycan Identified with a Soluble Receptor Reagent

References

• Aprelikova O., Pajusola K., Partanen J., Armstrong E., Alitalo R., Bailey S. K., McMahon J., Wasmuth J., Huebner K., Alitalo K. Flt4, a noval class III receptor tyrosine kinase in chromosome 5q33-qter. Cancer Res 1992; 52: 746–748
   PubMedGoogle Scholar
• Armitage R. J., Fanslow W. C., Strockbine L., Sato T. A., Clifford K. N., Macduff B. M., Anderson D. M., Gimpel S. D., Davis-Smith T., Maliszewski C. R., Clark E. A., Smith C. A., Grabstein K. H., Cosman D., Spriggs M. K. Molecular and biological characterization of a murine ligand for CD40. Nature 1992; 357: 80–82
   PubMed Web of Science ®Google Scholar
• Berger J., Hauber J., Hauber R., Geiger R., Cullen B. R. Secreted placental alkaline phosphatase: a powerful new quantitative indicator of gene expression in eukaryotic cells. Gene 1988; 66: 1–10
   PubMed Web of Science ®Google Scholar
• Bemfield M., Kokenyesi R., Kato M., Hinkes M. T., Spring J., Gallo R. L., Lose E. J. Biology of the syndecans: A family of transmembrane heparan sulfate proteoglycans. Annu. Rev. Cell Biol 1992; 8: 365–393
   PubMedGoogle Scholar
• Breier G., Albrecht U., Sterrer S., Risau W. Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation. Development 1992; 114: 521–532
   PubMed Web of Science ®Google Scholar
• Claffey K. P., Wilkison W. O., Spiegelman B. M. Vascular endothelial growth factor. Regulation by cell differentiation and activated second messenger pathways. J. Biol. Chem 1992; 267: 16317–16322
   PubMed Web of Science ®Google Scholar
• de Vries C., Escobedo J. A., Ueno H., Houck K., Ferrara N., Williams L. T. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 1992; 255: 989–991
   PubMed Web of Science ®Google Scholar
• Ferrara N., Houck K., Jakeman L., Leung D. W. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocrine Rev 1992; 13: 18–32
   PubMed Web of Science ®Google Scholar
• Flanagan J. G., Chan D. C., Leder P. Transmembrane form of the kit ligand growth factor is determined by alternative splicing and is missing in the Sld mutant. Cell 1991; 64: 1025–1035
   PubMed Web of Science ®Google Scholar
• Flanagan J. G., Leder P. The kit ligand a cell surface molecule altered in Steel mutant fibroblasts. Cell 1990; 63: 185–194
   PubMed Web of Science ®Google Scholar
• Folkman J., Klagsbrun M. Angiogenic factors. Science 1987; 235: 442–447
   PubMed Web of Science ®Google Scholar
• Galland F., Karamysheva A., Mattei M.-G., Rosnet O., Mar-Chetto S., Birnbaum D. Chromosomal localization of flt4, a noval receptor-type tyrosine kinase gene. Genomics 1992; 13: 475–478
   Google Scholar
• Gitay-Goren H., Soker S., Vlodavsky I., Neufeld G. The binding of vascular endothelial growth factor to its receptor is dependent on cell surface-associated heparin-like molecules. J. Biol. Chem 1992; 267: 6093–6098
   PubMed Web of Science ®Google Scholar
• Harlow E., Lane D. Antibodies: A Laboratory Manual. Cold Spring Harbor Laboratory, New York 1988
   Google Scholar
• Kan M., Wang F., Xu J., Crabb J. W., Hou J., McKeehan W. L. An essential heparin-binding domain in the fibroblast growth factor receptor kinase. Science 1993; 259: 1918–1921
   PubMed Web of Science ®Google Scholar
• Kim K. J., Li B., Winer J., Armanini M., Gillett N., Phillips H. S., Ferrara N. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth, in vivo. Nature 1993; 362: 841–844
   PubMed Web of Science ®Google Scholar
• Klagsbrun M., Baird A. A dual receptor system is required for basic fibroblast growth factor activity. Cell 1991; 67: 229–231
   PubMed Web of Science ®Google Scholar
• Lyman S. D., James L., Bos T. V., Vries P., Brasel K., Gliniak B., Hollingsworth L. T., Picha K. S., McKenna H. J., Splett R. R., Fletcher F. A., Maraskovsky E., Farrah T., Foxworthe D., Williams D. E., Beckmann M. P. Molecular cloning of a ligand for the flt3/flk-2 tyrosine kinase receptor: a proliferative factor for primitive hematopoietic cells. Cell 1993; 75: 1157–1167
   PubMed Web of Science ®Google Scholar
• Matsudaira P. Sequence from picomole quantities of proteins electroblotted onto polyvinylidene difluoride membranes. J. Biol. Chem 1987; 262: 10035–10038
   PubMed Web of Science ®Google Scholar
• Matthews W., Jordan C. T., Gavin M., Jenkins N. A., Copeland N. G., Lemischka I. R. A receptor tyrosine kinase cDNA isolated from a population of enriched primitive hematopoietic cells and exhibiting close genetic linkage to c-kit. Proc. Natl Acad. Sci. USA 1991; 88: 9026–9030
   PubMed Web of Science ®Google Scholar
• Millauer B., Shawver L. K., Plate K. H., Risau W., Ullrich A. Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature 1994; 367: 576–579
   PubMed Web of Science ®Google Scholar
• Millauer B., Wizigmann-Voos S., Schnurch H., Martinez R., Maller N. P. H., Risau W., Ullrich A. High affinity vegf binding and developmental expression suggest flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 1993; 72: 835–846
   PubMed Web of Science ®Google Scholar
• Munson P. J., Rodbard D. LIGAND: a versatile computerized approach for characterization of ligand-binding systems. Anal. Biochem 1980; 107: 220–239
   PubMed Web of Science ®Google Scholar
• Omitz D. M., Yayon A., Flanagan J. G., Svahn C. M., Levi E., Leder P. Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells. Mol. Cell. Biol 1992; 12: 240–247
   PubMed Web of Science ®Google Scholar
• Plate K. H., Breier G., Weich H. A., Risau W. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas, in vivo. Nature 1992; 359: 845–848
   PubMed Web of Science ®Google Scholar
• Quinn T. P., Peters K. G., Vries C. D., Ferrara N., Williams L. T. Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium. Proc. Natl Acad. Sci. USA 1993; 90: 7533–7537
   PubMed Web of Science ®Google Scholar
• Rapraeger A. C., Krufka A., Olwin B. B. Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation. Science 1991; 252: 1705–1707
   PubMed Web of Science ®Google Scholar
• Risau W. Embryonic angiogenesis factors. Pharmac. Ther 1991; 51: 371–376
   PubMed Web of Science ®Google Scholar
• Schlessinger J., Ullrich A. Growth factor signaling by receptor tyrosine kinases. Neuron 1992; 9: 383–391
   PubMed Web of Science ®Google Scholar
• Shweiki D., Itin A., Soffer D., Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992; 359: 843–845
   PubMed Web of Science ®Google Scholar
• Tempst P., Riviere L. Examination of automated polypeptide sequencing using standard phenyl isothiocyanate reagent and subpicomole high-performance liquid chromatographic analysis. Anal. Biochem 1989; 183: 290–300
   PubMedGoogle Scholar
• Terman B. I., Carrion M. E., Kovacs E., Rasmussen B. A., Eddy R. L., Shows T. B. Identification of a new endothelial cell growth factor receptor tyrosine kinase. Oncogene 1991; 6: 1677–1683
   PubMed Web of Science ®Google Scholar
• Terman B. I., Dougher-Vermazen M., Carrion M. E., Dimitrov D., Armellino D. C., Gospodarowicz D., Bohlen P. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem. Biophys. Res. Commun 1992; 187: 1579–1586
   PubMed Web of Science ®Google Scholar
• Tessler S., Rockwell P., Hicklin D., Cohen T., Levi B.-Z., Witte L., Lemischka I. R., Neufeld G. Heparin modulates the interaction of VEGF165 with soluble and cell associated flk-1 receptors. J. Biol. Chem 1994; 269: 12456–12461
   PubMed Web of Science ®Google Scholar
• Yayon A., Klagsbrun M., Esko J. D., Leder P., Omitz D. M. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 1991; 64: 841–848
   PubMed Web of Science ®Google Scholar
• Yeaman C., Rapraeger A. C. Membrane-anchored proteoglycans of mouse macrophages: P388D1 cells express a syndecan-4-like heparan sulfate proteoglycan and a distinct chondroitin sulfate form. J. Cell. Physiol 1993; 157: 413–425
   Google Scholar